Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Oner Sanli"'
Autor:
Yuval Freifeld, Hans J. Hammers, Aditya Bagrodia, Laura Maria Krabbe, Yair Lotan, Vitaly Margulis, Oner Sanli, Nirmish Singla, Timothy Clinton, Ryan Hutchinson, Raquibul Hannan, James Brugarolas, Justin T. Matulay, Solomon L. Woldu
Publikováno v:
Clinical Genitourinary Cancer. 16:e1221-e1235
Background The optimal timing of targeted therapy (TT) initiation for metastatic renal-cell carcinoma (mRCC) is not clear. We used a nationwide cancer registry to determine clinical and social factors associated with delayed TT and to evaluate the as
Publikováno v:
Nuclear Medicine Communications. 39:871-880
Treatment of high-risk prostate cancer (HRPCa) is challenging. Local staging and metastatic evaluation are important for the patient management. Recently, prostate-specific membrane antigen (PSMA)-based imaging modalities such as PSMA PET/CT and PET/
Autor:
Yair Lotan, Timothy Clinton, Oner Sanli, Raquibul Hannan, Aditya Bagrodia, Solomon L. Woldu, Andre Miranda, Aurelie Garant, Mark F. McLaughlin, Vitaly Margulis, Xiaosong Meng, Jeffrey Howard, Neil Desai
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:790.e1-790.e7
Purpose Metastasis-directed radiation therapy (MDRT) may improve oncologic and quality of life outcomes in patients with metastatic cancer, but data on its use in metastatic bladder cancer is severely limited. We sought to review our institutional ex
Publikováno v:
The ProstateREFERENCES. 80(2)
BACKGROUND AND AIM Upgrading after radical prostatectomy (RP) is an ongoing problem since first description of Gleason score. In this retrospective study, our aim is to investigate upgrading after RP in grade groups (GG) and clinical predictive, and
Publikováno v:
BJU International. 122:434-440
OBJECTIVES To model the cost-effectiveness of a biomarker-based approach to select patients for neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC). PATIENTS AND METHODS We obtained data from the mos
Publikováno v:
Nature Reviews Urology. 15:83-91
Urothelial carcinoma remains a clinical challenge: non-muscle-invasive disease has a high rate of recurrence and risk of progression, and outcomes for patients with advanced disease are poor, owing to a lack of effective systemic therapies. The Rho G
Autor:
Fikret Büyükkaya, Yasemin Sanli, Serkan Kuyumcu, Oner Sanli, Ayca Iribas, Göksel Alçin, Emin Darendeliler, Cuneyt Turkmen, Yasemin Ozluk, Sevda Ozel Yildiz
Publikováno v:
Annals of Nuclear Medicine. 31:709-717
To investigate the relationship between serum PSA level, Gleason score of PCa and the outcomes of Ga68-PSMA PET/CT in patients with recurrent PCa. A total of 109 consecutive patients (median age 71 years; range 48–89 years) who had PSA recurrence a
Publikováno v:
Biomedicines
Biomedicines, Vol 9, Iss 430, p 430 (2021)
Biomedicines, Vol 9, Iss 430, p 430 (2021)
The aim of this narrative review is to evaluate the current status of 177Lu-PSMA (prostate specific membrane antigen) therapy for metastatic castration-resistant prostate cancer (mCRPC) in the light of the current literature. We also addressed patien
Publikováno v:
The Prostate. 79(13)
BACKGROUND Active surveillance (AS) is one of the treatment alternatives in low-risk prostate cancer (PCa). The pathological upgrading after radical prostatectomy (RP) were investigated in patients who were eligible for AS in the present study. METHO
Autor:
Tayfun Oktar, Mazhar Ortac, Emre Salabas, Baris Yucel, Murat Tunc, Ismet Nane, Serkan Karakus, Tzevat Tefik, Oner Sanli, Abubekir Boyuk, Faruk Özcan, Necdet Aras, Selcuk Erdem
Publikováno v:
Journal of Minimal Access Surgery, Vol 12, Iss 1, Pp 33-40 (2016)
Journal of Minimal Access Surgery
Journal of Minimal Access Surgery
Aim: To evaluate the laparoscopic operations performed in our department according to the modified Clavien classification system of complications. Materials and Methods: Between September, 2005 and February, 2014, a total of 1023 laparoscopic cases w